References
1. Olsen etal 2005, Sacccheti M, Dela F, Ploug T, Satlin B. Glucose Clearance is higher in arm than leg muscle in type II diabetes of physiology 2005; 555-562.
2. Martin I. K, A. Katz, J. Wahren (1995). Splanchnic and muscle metabolism during exercise in NIDDM patients. AMJ Physiol 269: E583-E590.
3. Williams MA, Haskell WL, Ades PA. Resistance exercise in individuals with and without cardiovascular disease: 2007, Circulation. 2007 Jul 31; 116(5):572-84.
4. Dr.S.S.Subramanian, Single Bout of Resisted Exercises Using Physioball on Random Blood Sugar on a Female Type II Diabetes Mellitus.
5. J.J.S Larsen, F.Dela, S.Madsbad N Galbo.1999,the effect of intense exercise on postprandial glucose homeostasis in type 2 diabetic patients Diabetologia(1999) 42:1282-1292
6. Alexandre G oliveira, BrunoM. Carvalho etal physical exercises reduce circulating lip polysaccharides .Department of internal medicine, Brazil, ADA 2010.
7. Kennedy J.V, Nirshman MF, GERVINOev etal. Acute exercise induces GLUT4 translocation in skeletal muscle diabetes 1994 48:1192-97.
8. Dela. F, Mikines KJ SONNE B, Galbo M (1994) Effect of training on nineraction between insulin and exercise in human muscle J.APL. Physiology 76:2386-2393
9. Defronzo RA, Bonadonna RC & Ferrannini E (1992). Pathogenesis of NIDDM – A balanced overview. Diabetes care 15, 318-368.
10. Dela F, Mikines KJ, Larsen JJ, Ploug T, Petersen LN & Galbo H (1995). Insulin stimulated muscle glucose clearance in patients with type II diabetes mellitus. Effects of one – legged physical training, diabetes 44, 1010-1020.
11. Basu A, Basu R, Shah P, Vella A, Johnson CM, Nair KS, Jensen MD, Schwenk WF & Rizza RA (2000). Effects of type II diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism; evidence for a defect in hepatic glucokinase activity. Diabetes 49, 272-283.
12. Goodyear LJ, Hirshman MF, Smith RJ & Horton ES (1991). Glucose transporter number, activity, and isoform content in plasma membranes of red and white skeletal muscle. AMJ Physiol 261, E556-E561.
13. Schantz P, Randall – Fox E, Hutchinson W, tyden A & Astrand P- O (1983). Muscle fibre type distribution, muscle cross- sectional area and maximal voluntary strength in humans. Acta physiol scand 117, 219-226.
14. Enevoldsen LH, Simonsen L, Stallknecht B, Galbo and Bulow J 2001. In Vivo human lipolytic activity in preperitoneal and subdivisions of subcutaneous adipose tissue. AMJ physiol Endocrinal Metab 281; E1110-E1114.
15. Gaster M, Staehr P, beck – Nielsen H, Schroder DD & Handberg A (2001). GLUT4 is reduced in slow muscle fibres of type II diabetic patients: is insulin resistance in type II diabetic patients: is insulin resistance in type II diabetes a slow, type I fiber disease? Diabetes 50, 1324-1329.
16. Avogaro A, Toffolo G, Miola M, Valerio A, Tiengo A, Cobelli C, & Del prato S (1996). Intracellular lactate – and pyruvate – interconversion rates are increased in muscle tissue of non-insulin dependent diabetic individuals. J Clin Invest 98, 108-115.
17. Blaak EE & Wagenmakers AJ (200). The fate of [U-13 C] palmitate extracted by skeletal muscle in subjects with type II diabetes and control subjects. Diabetes 51, 784-789.
18. Huonker M, Schmid A, Schmidt – Trucksass A, Grathwohl D & Keul J (2003). Size and blood flow of central and peripheral arteries in highly trained able – bodied and disabled athletes. J Appl Physiol 95, 685-691.
19. New Comer SC, Leven Berger UA, Hageman CS. Handy BD and proctor DN 2004 different vasodilator responses of human arms and legs. J- Physiol 556, 1001-1011.
20. Bucciarelli P, Sramek A, Reiber JH & Rosendaal FR (2002). Arterial intima – media thickness and its relationship with cardiovascular disease and atherosclerosis: a possible contribution of medium sized arteries. Thromb Haemost 88, 961-966.
21. Sorensen KE, Kristensen IB and Celermajer DS 1997. Arthrosclerosis in the human brachial artery. J- AM Coll Cardiol 29, 318-322.